Catalyst

$CRL

- Provides drug discovery and preclinical services.

CRL

$215.75

+1.43%

What changed

$CRL - Provides drug discovery and preclinical services. - REV +1.2% to $1.0B - EPS $2.06

Why it matters

Q3 earnings beat estimates by 12%, driven by 18% oncology revenue growth.

Sources

pipeline